Product Images Crestor

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Crestor NDC 68151-4634 by Carilion Materials Management, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

strucural formula - 3a498c46 5ad2 416a 875e 18e48b586954 01

strucural formula - 3a498c46 5ad2 416a 875e 18e48b586954 01

figure one - 3a498c46 5ad2 416a 875e 18e48b586954 02

figure one - 3a498c46 5ad2 416a 875e 18e48b586954 02

figure two - 3a498c46 5ad2 416a 875e 18e48b586954 03

figure two - 3a498c46 5ad2 416a 875e 18e48b586954 03

The text describes cumulative incidence rates in a study comparing the effectiveness of the drug RSV to a placebo. The study found that RSV had a statistically significant effect (HR 0.56, 95% CI 0.46-0.69, p<0.001) in reducing incidence rates. The number at risk in the study were 8901 individuals who received RSV and 8801 who received the placebo. The data is presented over several years.*

figure three - 3a498c46 5ad2 416a 875e 18e48b586954 04

figure three - 3a498c46 5ad2 416a 875e 18e48b586954 04

The text describes a study evaluating the effect of a drug on various endpoints in a group of patients. The number of events that occurred in the treatment group and the placebo group were recorded for each endpoint. The primary endpoint was a composite of multiple events, and the treatment group showed a significant reduction in this endpoint compared to placebo. The other endpoints evaluated were cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The number of events and event rates for each endpoint were reported. The definition of cardiovascular death is also provided.*

Label Image - lbl681514634

Label Image - lbl681514634

This is a medication label for Crestor, a brand name of the drug rosuvastatin calcium. The medication comes in the form of tablets in 5 mg strength, manufactured by Corden Pharma. The lot number is B0039, and the expiration date is 07/14. It is available only with a prescription.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.